loading page

Immune checkpoint inhibitors combined with chemotherapy/antiangiogenic therapy for heavily treated advanced lung cancer patients with EGFR mutation: a retrospective analysis
  • +4
  • Ran Hu,
  • Zhiting Zhao,
  • Yue Shi,
  • Meiqi Shi,
  • Guohao Xia,
  • Shaorong Yu,
  • Jifeng Feng
Ran Hu
Jiangsu Cancer Hospital
Author Profile
Zhiting Zhao
Jiangsu Cancer Hospital
Author Profile
Yue Shi
Jiangsu Cancer Hospital
Author Profile
Meiqi Shi
Jiangsu Cancer Hospital
Author Profile
Guohao Xia
Jiangsu Cancer Hospital
Author Profile
Shaorong Yu
Jiangsu Cancer Hospital
Author Profile
Jifeng Feng
Author Profile